ORBIMED ADVISORS LLC
CIK 1055951
Transactions on file
101
Open-market buys
17
Win rate (buys)
94%
17 scored
Avg % since filing (buys)
+306.9%
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-29 | 2026-07-27 | SCTX Scribe Therapeutics, Inc. | Director | Buy | 1,000,000 | $15.00M | +29.7% | open → |
| 2026-07-29 | 2026-07-27 | SCTX Scribe Therapeutics, Inc. | Director | C | 348,825 | $0.00 | — | open → |
| 2026-07-09 | 2026-07-07 | SION Sionna Therapeutics, Inc. | Director | Sale | 85,918 | $3.85M | +5.1% | open → |
| 2026-07-02 | 2026-06-30 | SION Sionna Therapeutics, Inc. | Director | Sale | 115,844 | $5.27M | +3.6% | open → |
| 2026-06-24 | 2026-06-22 | ELVN Enliven Therapeutics, Inc. | 10% | Sale | 46,776 | $2.10M | +21.8% | open → |
| 2026-06-24 | 2026-06-22 | ELVN Enliven Therapeutics, Inc. | 10% | Sale | 787,024 | $35.72M | +20.8% | open → |
| 2026-06-24 | 2026-06-22 | ELVN Enliven Therapeutics, Inc. | 10% | Sale | 1,477 | $66.5K | +21.8% | open → |
| 2026-06-24 | 2026-06-22 | ELVN Enliven Therapeutics, Inc. | 10% | Sale | 24,846 | $1.13M | +20.8% | open → |
| 2026-06-17 | 2026-06-15 | ELVN Enliven Therapeutics, Inc. | 10% | Sale | 272,322 | $12.26M | +21.7% | open → |
| 2026-06-17 | 2026-06-15 | ELVN Enliven Therapeutics, Inc. | 10% | Sale | 9,086 | $409.1K | +21.7% | open → |
| 2026-06-02 | 2026-05-28 | QTTB Q32 Bio Inc. | Director10% | Buy | 625,000 | $5.00M | +96.0% | open → |
| 2026-06-02 | 2026-05-28 | QTTB Q32 Bio Inc. | Director10% | Buy | 1,250,000 | $10.00M | +96.0% | open → |
| 2026-05-30 | 2026-05-27 | SION Sionna Therapeutics, Inc. | Director | Sale | 101 | $4.5K | +5.9% | open → |
| 2026-05-11 | 2026-05-11 | SION Sionna Therapeutics, Inc. | Director | Sale | 184,639 | $8.53M | +2.0% | open → |
| 2026-05-11 | 2026-05-08 | SION Sionna Therapeutics, Inc. | Director | Sale | 59,767 | $2.66M | +5.7% | open → |
| 2026-05-11 | 2026-05-07 | SION Sionna Therapeutics, Inc. | Director | Sale | 48,546 | $2.17M | +5.6% | open → |
| 2026-04-28 | 2026-04-16 | TRAW Traws Pharma, Inc. | 10% | Buy | 597,729 | $998.2K | -73.1% | open → |
| 2026-04-23 | 2026-04-21 | PRLD Prelude Therapeutics Inc | Director10% | Buy | 1,126,126 | $5.00M | +10.6% | open → |
| 2026-04-23 | 2026-04-21 | PRLD Prelude Therapeutics Inc | Director10% | Buy | 1,689,189 | $7.50M | +10.6% | open → |
| 2026-04-21 | 2026-04-18 | SION Sionna Therapeutics, Inc. | Director | Sale | 2,948 | $131.2K | +5.9% | open → |
| 2026-04-21 | 2026-04-17 | SION Sionna Therapeutics, Inc. | Director | Sale | 52,397 | $2.34M | +5.5% | open → |
| 2026-04-16 | 2026-04-16 | SION Sionna Therapeutics, Inc. | Director | Sale | 226,906 | $10.29M | +3.9% | open → |
| 2026-04-16 | 2026-04-15 | SION Sionna Therapeutics, Inc. | Director | Sale | 235,863 | $10.53M | +5.6% | open → |
| 2026-04-16 | 2026-04-14 | SION Sionna Therapeutics, Inc. | Director | Sale | 47,814 | $2.13M | +5.9% | open → |
| 2026-04-09 | 2026-04-08 | ACET Adicet Bio, Inc. | 10% | Sale | 40,416 | $263.5K | +31.4% | open → |
| 2026-04-09 | 2026-04-08 | ACET Adicet Bio, Inc. | 10% | Sale | 32,523 | $204.6K | +36.2% | open → |
| 2026-04-09 | 2026-04-07 | ACET Adicet Bio, Inc. | 10% | Sale | 2,400 | $15.3K | +34.3% | open → |
| 2026-04-09 | 2026-04-07 | ACET Adicet Bio, Inc. | 10% | Sale | 29,319 | $191.5K | +31.2% | open → |
| 2025-01-08 | 2025-01-08 | PASG Passage BIO, Inc. | 10% | Sale | 75,007 | $51.0K | +579.4% | open → |
| 2025-01-08 | 2025-01-07 | PASG Passage BIO, Inc. | 10% | Sale | 52,536 | $37.3K | +550.7% | open → |
| 2025-01-08 | 2025-01-06 | PASG Passage BIO, Inc. | 10% | Sale | 19,481 | $15.0K | +500.0% | open → |
| 2025-01-14 | 2025-01-14 | PASG Passage BIO, Inc. | 10% | Sale | 79,024 | $47.4K | +670.0% | open → |
| 2025-01-14 | 2025-01-10 | PASG Passage BIO, Inc. | 10% | Sale | 126,209 | $83.3K | +600.0% | open → |
| 2025-01-14 | 2025-01-13 | PASG Passage BIO, Inc. | 10% | Sale | 17,986 | $11.5K | +621.9% | open → |
| 2025-02-10 | 2025-02-10 | SION Sionna Therapeutics, Inc. | Director | Buy | 550,000 | $9.90M | +161.8% | open → |
| 2025-02-10 | 2025-02-10 | SION Sionna Therapeutics, Inc. | Director | C | 3,154,959 | — | — | open → |
| 2025-02-19 | 2025-02-14 | MBX MBX Biosciences, Inc. | Director10% | Buy | 29,540 | $291.0K | +467.7% | open → |
| 2025-02-19 | 2025-02-18 | MBX MBX Biosciences, Inc. | Director10% | Buy | 49,070 | $531.9K | +415.9% | open → |
| 2025-02-19 | 2025-02-14 | MBX MBX Biosciences, Inc. | Director10% | Buy | 17,962 | $177.8K | +464.8% | open → |
| 2025-02-19 | 2025-02-18 | MBX MBX Biosciences, Inc. | Director10% | Buy | 94,100 | $1.02M | +415.9% | open → |
| 2025-03-12 | 2025-03-10 | IRON Disc Medicine, Inc. | Director | Sale | 68,766 | $3.73M | +41.8% | open → |
| 2025-03-12 | 2025-03-12 | IRON Disc Medicine, Inc. | Director | Sale | 10,733 | $584.3K | +41.4% | open → |
| 2025-03-12 | 2025-03-10 | IRON Disc Medicine, Inc. | Director | Sale | 106,384 | $5.78M | +41.8% | open → |
| 2025-03-12 | 2025-03-10 | IRON Disc Medicine, Inc. | Director | Sale | 26,596 | $1.44M | +41.8% | open → |
| 2025-03-12 | 2025-03-10 | IRON Disc Medicine, Inc. | Director | Sale | 136 | $7.5K | +40.0% | open → |
| 2025-03-12 | 2025-03-10 | IRON Disc Medicine, Inc. | Director | Sale | 211 | $11.6K | +40.0% | open → |
| 2025-03-12 | 2025-03-10 | IRON Disc Medicine, Inc. | Director | Sale | 53 | $2.9K | +40.0% | open → |
| 2025-03-12 | 2025-03-11 | IRON Disc Medicine, Inc. | Director | Sale | 9,222 | $498.1K | +42.6% | open → |
| 2025-03-12 | 2025-03-11 | IRON Disc Medicine, Inc. | Director | Sale | 14,267 | $770.6K | +42.6% | open → |
| 2025-03-12 | 2025-03-11 | IRON Disc Medicine, Inc. | Director | Sale | 3,567 | $192.7K | +42.6% | open → |
| 2025-03-12 | 2025-03-12 | IRON Disc Medicine, Inc. | Director | Sale | 603 | $33.2K | +39.9% | open → |
| 2025-03-12 | 2025-03-12 | IRON Disc Medicine, Inc. | Director | Sale | 933 | $51.4K | +39.9% | open → |
| 2025-03-12 | 2025-03-12 | IRON Disc Medicine, Inc. | Director | Sale | 233 | $12.8K | +39.9% | open → |
| 2025-03-12 | 2025-03-12 | IRON Disc Medicine, Inc. | Director | Sale | 42,930 | $2.34M | +41.4% | open → |
| 2025-03-12 | 2025-03-12 | IRON Disc Medicine, Inc. | Director | Sale | 27,750 | $1.51M | +41.4% | open → |
| 2025-03-21 | 2025-03-20 | IRON Disc Medicine, Inc. | Director | Sale | 364 | $19.7K | +42.6% | open → |
| 2025-03-21 | 2025-03-20 | IRON Disc Medicine, Inc. | Director | Sale | 1,457 | $78.7K | +42.6% | open → |
| 2025-03-21 | 2025-03-20 | IRON Disc Medicine, Inc. | Director | Sale | 941 | $50.8K | +42.6% | open → |
| 2025-03-21 | 2025-03-19 | IRON Disc Medicine, Inc. | Director | Sale | 5,228 | $282.4K | +42.5% | open → |
| 2025-03-21 | 2025-03-19 | IRON Disc Medicine, Inc. | Director | Sale | 20,911 | $1.13M | +42.5% | open → |
| 2025-03-21 | 2025-03-19 | IRON Disc Medicine, Inc. | Director | Sale | 13,517 | $730.2K | +42.5% | open → |
| 2025-03-21 | 2025-03-21 | IRON Disc Medicine, Inc. | Director | Sale | 1,320 | $71.3K | +42.6% | open → |
| 2025-03-21 | 2025-03-21 | IRON Disc Medicine, Inc. | Director | Sale | 5,279 | $285.1K | +42.6% | open → |
| 2025-03-21 | 2025-03-21 | IRON Disc Medicine, Inc. | Director | Sale | 3,412 | $184.2K | +42.6% | open → |
| 2025-03-26 | 2025-03-24 | IRON Disc Medicine, Inc. | Director | Sale | 1,956 | $105.8K | +42.3% | open → |
| 2025-03-26 | 2025-03-24 | IRON Disc Medicine, Inc. | Director | Sale | 3,026 | $163.7K | +42.3% | open → |
| 2025-03-26 | 2025-03-24 | IRON Disc Medicine, Inc. | Director | Sale | 756 | $40.9K | +42.3% | open → |
| 2025-04-04 | 2025-04-03 | EWTX Edgewise Therapeutics, Inc. | Director10% | Buy | 372,578 | $7.50M | +90.9% | open → |
| 2025-04-04 | 2025-04-03 | EWTX Edgewise Therapeutics, Inc. | Director10% | Buy | 124,193 | $2.50M | +90.9% | open → |
| 2025-04-11 | 2025-04-09 | CMPX Compass Therapeutics, Inc. | Director10% | Sale | 3,571,428 | $5.68M | — | open → |
| 2025-04-14 | 2025-04-10 | XTNT Xtant Medical Holdings, Inc. | 10% | Sale | 56,004,974 | $23.52M | — | open → |
| 2025-04-14 | 2025-04-10 | XTNT Xtant Medical Holdings, Inc. | 10% | Sale | 17,109,618 | $7.19M | — | open → |
| 2025-04-17 | 2025-04-17 | PASG Passage BIO, Inc. | 10% | Sale | 77,090 | $25.4K | +1300.0% | open → |
| 2025-04-17 | 2025-04-16 | PASG Passage BIO, Inc. | 10% | Sale | 61,638 | $20.3K | +1300.0% | open → |
| 2025-04-17 | 2025-04-15 | PASG Passage BIO, Inc. | 10% | Sale | 10,326 | $3.9K | +1115.8% | open → |
| 2025-04-24 | 2025-04-22 | PASG Passage BIO, Inc. | 10% | Sale | 78,049 | $26.5K | +1258.8% | open → |
| 2025-04-24 | 2025-04-23 | PASG Passage BIO, Inc. | 10% | Sale | 89,328 | $30.4K | +1258.8% | open → |
| 2025-04-24 | 2025-04-24 | PASG Passage BIO, Inc. | 10% | Sale | 68,195 | $21.8K | +1343.8% | open → |
| 2025-05-16 | 2025-05-14 | NPCE NeuroPace Inc | 10% | Sale | 134,136 | $2.12M | -6.4% | open → |
| 2025-05-16 | 2025-05-14 | NPCE NeuroPace Inc | 10% | Sale | 34,000 | $542.0K | -7.1% | open → |
| 2025-06-26 | 2025-06-25 | PASG Passage BIO, Inc. | 10% | Sale | 138,800 | $45.8K | +1300.0% | open → |
| 2025-06-26 | 2025-06-26 | PASG Passage BIO, Inc. | 10% | Sale | 213,257 | $70.4K | +1300.0% | open → |
| 2025-06-26 | 2025-06-24 | PASG Passage BIO, Inc. | 10% | Sale | 231,600 | $81.1K | +1220.0% | open → |
| 2025-12-19 | 2025-12-19 | SION Sionna Therapeutics, Inc. | Director | Sale | 875 | $38.9K | +5.9% | open → |
| 2025-12-19 | 2025-12-18 | SION Sionna Therapeutics, Inc. | Director | Sale | 100 | $4.4K | +5.9% | open → |
| 2025-12-19 | 2025-12-17 | SION Sionna Therapeutics, Inc. | Director | Sale | 900 | $40.0K | +5.9% | open → |
| 2025-12-18 | 2025-11-21 | KROS Keros Therapeutics, Inc. | Director | Disp. | 74,465 | $1.32M | -43.3% | open → |
| 2025-12-18 | 2025-11-21 | KROS Keros Therapeutics, Inc. | Director | Disp. | 140,057 | $2.49M | -43.3% | open → |
| 2025-11-26 | 2025-11-26 | SION Sionna Therapeutics, Inc. | Director | Sale | 1,600 | $71.2K | +5.9% | open → |
| 2025-11-26 | 2025-11-25 | SION Sionna Therapeutics, Inc. | Director | Sale | 11,890 | $530.3K | +5.7% | open → |
| 2025-11-26 | 2025-11-24 | SION Sionna Therapeutics, Inc. | Director | Sale | 94,583 | $4.21M | +5.8% | open → |
| 2025-10-27 | 2025-10-23 | PMVP PMV Pharmaceuticals, Inc. | 10% | Sale | 1,000,000 | $1.52M | -19.7% | open → |
| 2025-10-10 | 2025-10-08 | ACET Adicet Bio, Inc. | 10% | Buy | 3,500,000 | $3.50M | +757.0% | open → |
| 2025-10-10 | 2025-10-08 | ACET Adicet Bio, Inc. | 10% | Buy | 1,500,000 | $1.50M | +757.0% | open → |
| 2025-07-01 | 2025-06-27 | CRVS Corvus Pharmaceuticals, Inc. | Director10% | X | 1,397,684 | $4.89M | +327.7% | open → |
| 2025-07-01 | 2025-06-27 | CRVS Corvus Pharmaceuticals, Inc. | Director10% | Sale | 1,176,332 | $4.89M | +259.9% | open → |
| 2025-07-30 | 2025-07-25 | IKNA ImageneBio, Inc. | Director | Grant | 83,611 | $208.2K | — | open → |
| 2025-08-12 | 2025-08-08 | TSBX Turnstone Biologics Corp. | Director | U | 3,099,265 | — | — | open → |
| 2025-09-02 | 2025-08-25 | STTK Shattuck Labs, Inc. | Director | Buy | 1,051,021 | $914.4K | +712.6% | open → |
| 2025-09-02 | 2025-08-25 | STTK Shattuck Labs, Inc. | Director | Buy | 5,255,106 | $4.57M | +712.6% | open → |
